Related Experiment Video
Updated: May 28, 2026

Sub-acute Cerebral Microhemorrhages Induced by Lipopolysaccharide Injection in Rats
Published on: October 17, 2018
Aspirin treatment increases the risk of cerebral microbleeds
Lihong Ge1, Guangming Niu, Xiaodong Han
1Department of Imaging, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.
Background:
The objective of the study was to determine the frequency of cerebral microbleeds (CMBs) by using phasesensitive imaging in patients with previous transient ischemic attack (TIA) or stroke who were receiving aspirin treatment.
Methods:
We retrospectively analyzed 300 outpatients with ischemic cerebrovascular disease: 150 had been receiving aspirin treatment for >1 year (patients), and 150 controls had not previously received aspirin. Cerebral microbleeds were defined by a trained observer (blinded to clinical details) according to results of T2-weighted, T1-weighted, diffusion-weighted, and phase-sensitive magnetic resonance imaging (MRI). Numerous vascular risk factors including white matter hyperintensity (WMH), duration of aspirin treatment, age, hypertension or diabetes mellitus were investigated for a possible association with the presence of CMBs in the two groups.
Results:
The frequency of CMBs (60/150 (40%) vs 18/150 (12%); odds ratio 4.899, p <0.0001) and intracerebral hemorrhage (ICH)(42/150 (28%) vs 2/150 (1%); odds ratio 28.778, p <0.0001) were significantly higher in the patients than in the controls. Among patients, those using aspirin for >5 years(42/68 (62%) showed a higher frequency of CMBs than those receiving aspirin for ≤ 5 years(18/82 (22%); odds ratio 5.744, p<0.0001). WMH (p=0.020/0.030, 0.007/0.000) age (p=0.007/0.000) and hypertension (p=0.000/0.033), in patients and controls respectively, were each associated with CMBs.
Conclusions:
There was a clear impact of aspirin treatment on CMBs associated with intracerebral hemorrhage in Chinese patients. The frequency of CMBs and hemorrhagic complications was higher in patients treated with long-term aspirin.
Insights
Long-term aspirin use in Chinese patients with a history of stroke or TIA significantly increases the risk of cerebral microbleeds (CMBs) and intracerebral hemorrhage (ICH). This highlights the importance of monitoring for these complications in patients on long-term aspirin therapy.
Area of Science:
- Neurology
- Radiology
- Pharmacology
Background:
- Cerebral microbleeds (CMBs) are small hemorrhages in the brain, often associated with cerebrovascular disease.
- Aspirin is commonly prescribed for patients with a history of transient ischemic attack (TIA) or stroke to prevent further events.
- Phase-sensitive imaging offers advanced detection capabilities for CMBs.
Purpose of the Study:
- To investigate the frequency of cerebral microbleeds (CMBs) in patients with a history of TIA or stroke undergoing aspirin treatment.
- To compare CMB prevalence between patients on long-term aspirin and controls not receiving aspirin.
- To identify risk factors associated with CMBs in these patient groups.
Main Methods:
- Retrospective analysis of 300 outpatients with ischemic cerebrovascular disease.
- Two groups were studied: 150 patients on aspirin for >1 year and 150 controls without prior aspirin use.
- Cerebral microbleeds were identified using phase-sensitive magnetic resonance imaging (MRI) and other MRI sequences by a blinded observer. Vascular risk factors were also assessed.
Main Results:
- The frequency of CMBs was significantly higher in aspirin-treated patients (40%) compared to controls (12%).
- Intracerebral hemorrhage (ICH) was also significantly more frequent in the aspirin group (28% vs 1%).
- Long-term aspirin use (>5 years) was associated with a substantially higher CMB frequency (62% vs 22%). White matter hyperintensity, age, and hypertension were also linked to CMBs.
Conclusions:
- Aspirin treatment, particularly long-term use, significantly increases the occurrence of CMBs and associated intracerebral hemorrhage in Chinese patients with a history of ischemic cerebrovascular events.
- The findings underscore the impact of aspirin on hemorrhagic complications in this patient population.
- Phase-sensitive imaging is a valuable tool for detecting CMBs.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
